(S)-Ethyl2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol -1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate

CAS: 1033805-22-9

Ref. 3D-FE157240

Información del producto

• Nombre: (S)-Ethyl2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol -1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate
• Sinónimos: LX- 1606 (Hippurate), (2S)-2-Amino-3-[4-[2-amino-6-[[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethyl]oxy]pyrimidin-4-yl]phenyl]propionic acid ethyl ester, 4-[2-Amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-<span class="text-smallcaps">L</span>-phenylalanine ethyl ester, <span class="text-smallcaps">L</span>-Phenylalanine, 4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-, ethyl ester, Lx 1032, Lx 1606, Lx1032, Telotristat ethyl, Xermelo
• CAS: 1033805-22-9

Descripción

Telotristat ethyl is a pharmacological treatment for carcinoid syndrome, which is caused by the release of serotonin from enterochromaffin cells in the intestine. Telotristat ethyl inhibits serotonin release by reversibly inhibiting serotonin release from enterochromaffin cells and other cell types that express 5-HT4 receptors. This drug has no effect on the release of histamine or acetylcholine and does not cross the blood-brain barrier. Telotristat ethyl has shown long-term efficacy in people with carcinoid syndrome and minimal toxicity profiles. The most common side effects are diarrhoea, nausea, vomiting, abdominal pain, headache, and dizziness.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 574.98 g/mol
• Fórmula: C₂₇H₂₆ClF₃N₆O₃
• Pureza: Min. 95%